Document is current

Any future updates will be listed below

Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)

Crossref DOI link: https://doi.org/10.1186/s13063-020-04608-4

Published Online: 2020-07-19

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark